On Thursday, Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA), lost -2.55% to $69.07.
Teva Pharmaceutical Industries Limited stated results for the quarter ended June 30, 2015.
Second Quarter 2015 Results
Revenues in the second quarter of 2015 amounted to $5.0 billion, down 2% contrast to the second quarter of 2014. Not taking into account the impact of foreign exchange fluctuations and the sale of our U.S. OTC plants in July 2014, revenues grew 6%.
Exchange rate differences (net of profits from certain hedging transactions) between the second quarter of 2015 and the second quarter of 2014 reduced our revenues by $341 million and reduced our non-GAAP operating income by $4 million but raised our GAAP operating income by $17 million.
Non-GAAP gross profit was $3.1 billion in the second quarter of 2015, up 7% from the second quarter of 2014. Non-GAAP gross profit margin was 62.8% in the second quarter of 2015, contrast to 58.1% in the second quarter of 2014. GAAP gross profit was $2.9 billion in the second quarter of 2015, contrast to $2.7 billion in the second quarter of 2014. GAAP gross profit margin was 58.4% in the quarter, contrast to 52.7% in the second quarter of 2014.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines.
Shares of BorgWarner Inc. (NYSE:BWA), declined -4.92% to $49.85, during its last trading session, hitting its lowest level.
BorgWarner stated second quarter 2015 U.S. GAAP net earnings of $0.65 per diluted share. Not taking into account non-comparable items, net earnings were $0.75 per diluted share. Net sales were $2,032 million in the quarter.
Second Quarter Highlights:
- S. GAAP net sales of $2,032 million, down 7% contrast with second quarter 2014.
- The impact of foreign currencies reduced second quarter 2015 net sales growth by about 11% contrast with second quarter 2014.
- Not taking into account the impact of foreign currencies, net sales were up 4% contrast with second quarter 2014.
- S. GAAP net earnings of $0.65 per diluted share.
- Not taking into account the $(0.08) per diluted share impact of restructuring and the $(0.02) per diluted share impact of tax adjustments, net earnings were $0.75 per diluted share.
- The impact of foreign currencies reduced net earnings by about $0.09 per diluted share in second quarter 2015 contrast with second quarter 2014.
- S. GAAP operating income of $243 million.
- Not taking into account the $20 million pretax impact of restructuring expense, operating income was $262 million, or 12.9% of net sales, down from 13.5% in second quarter 2014.
BorgWarner Inc. manufactures and sells engineered automotive systems and components primarily for powertrain applications worldwide. The company’s Engine segment offers turbochargers, timing devices and chain products, emissions systems, thermal systems, and diesel coldstart and gasoline ignition technology. This segment also provides electric air pumps; turbo actuators; and exhaust gas recirculation coolers, tubes, and valves for gasoline and diesel applications.
Finally, Tyson Foods, Inc. (NYSE:TSN), ended its last trade with 1.28% gain, and closed at $44.38.
Tyson Foods, will hold its fiscal third quarter 2015 earnings conference call Monday, August 3, at 9 a.m. Eastern (8 a.m. Central).
Tyson Foods, Inc., together with its auxiliaries, produces, distributes, and markets chicken, beef, pork, prepared foods, and related allied products worldwide. The company breeds and raises chickens; and processes live chickens into fresh, frozen, and value-added chicken products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
